These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1632784)

  • 1. Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in Alzheimer's disease.
    Kalaria RN; Kroon SN
    Biochem Biophys Res Commun; 1992 Jul; 186(1):461-6. PubMed ID: 1632784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid P component and other acute-phase proteins associated with cerebellar A beta-deposits in Alzheimer's disease.
    Kalaria RN; Perry G
    Brain Res; 1993 Dec; 631(1):151-5. PubMed ID: 7507788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells.
    Trouw LA; Nielsen HM; Minthon L; Londos E; Landberg G; Veerhuis R; Janciauskiene S; Blom AM
    Mol Immunol; 2008 Aug; 45(13):3649-60. PubMed ID: 18556068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation.
    García de Frutos P; Dahlbäck B
    J Immunol; 1994 Mar; 152(5):2430-7. PubMed ID: 8133054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-P-component-like immunoreactivity in beta/A4-immunoreactive deposits in Alzheimer-type dementia brains.
    Kimura M; Arai H; Takahashi T; Iwamoto N
    J Neurol; 1994 Jan; 241(3):170-4. PubMed ID: 8164020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
    Coria F; Castaño E; Prelli F; Larrondo-Lillo M; van Duinen S; Shelanski ML; Frangione B
    Lab Invest; 1988 Apr; 58(4):454-8. PubMed ID: 2965774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of amyloid P component with complement proteins in neurologically diseased brain tissue.
    Akiyama H; Yamada T; Kawamata T; McGeer PL
    Brain Res; 1991 May; 548(1-2):349-52. PubMed ID: 1831062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular deposition of C4 cleavage fragment (C4d) and C4-binding protein in idiopathic membranous glomerulonephritis.
    Kusunoki Y; Itami N; Tochimaru H; Takekoshi Y; Nagasawa S; Yoshiki T
    Nephron; 1989; 51(1):17-9. PubMed ID: 2644563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
    Coria F; Castaño EM; Frangione B
    Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease.
    Rozemuller JM; Stam FC; Eikelenboom P
    Neurosci Lett; 1990 Oct; 119(1):75-8. PubMed ID: 1711182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody 9D5 recognizes oligomeric pyroglutamate amyloid-β in a fraction of amyloid-β deposits in Alzheimer's disease without cross-reactivity with other protein aggregates.
    Venkataramani V; Wirths O; Budka H; Härtig W; Kovacs GG; Bayer TA
    J Alzheimers Dis; 2012; 29(2):361-71. PubMed ID: 22232007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease.
    Rostagno A; Lashley T; Ng D; Meyerson J; Braendgaard H; Plant G; Bojsen-Møller M; Holton J; Frangione B; Revesz T; Ghiso J
    J Neurol Sci; 2007 Jun; 257(1-2):88-96. PubMed ID: 17374542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a stable fragment of the Alzheimer amyloid precursor containing the beta-protein in brain microvessels.
    Tamaoka A; Kalaria RN; Lieberburg I; Selkoe DJ
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1345-9. PubMed ID: 1531538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of a covalent-like interaction between soluble nascent C4b and C4-binding protein.
    Villiers MB; Thielens NM; Reboul A; Colomb MG
    Biochim Biophys Acta; 1982 Jun; 704(2):197-203. PubMed ID: 6980671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's disease.
    Hawkins PN; Rossor MN; Gallimore JR; Miller B; Moore EG; Pepys MB
    Biochem Biophys Res Commun; 1994 Jun; 201(2):722-6. PubMed ID: 7516157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
    Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
    Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.